Zenas BioPharma, Inc. (ZBIO)
21.74
+0.69
(+3.28%)
USD |
NASDAQ |
Apr 16, 16:00
21.74
0.00 (0.00%)
After-Hours: 20:00
Zenas BioPharma Total Assets (Quarterly) : 383.64M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 633.35M |
| AnaptysBio, Inc. | 364.40M |
| Gilead Sciences, Inc. | 59.02B |
| Nkarta, Inc. | 417.29M |
| Cullinan Therapeutics, Inc. | 449.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 141.50M |
| Shareholders Equity (Quarterly) | 242.14M |
| Debt to Equity Ratio | 0.3302 |
| Current Ratio | 5.605 |
| Net Debt Paydown Yield | -0.80% |